Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) — The “Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial Stoppers (RTU), Cartridge, Cell Therapy Bags), Instruments (Integrated, Automated)), Fill Finish Service, End User – Global Forecast to 2030” has been added to ResearchAndMarkets.com’s offering.
The global fill finish manufacturing market is anticipated to reach USD 28.14 billion by 2030, growing from USD 18.36 billion in 2025 at a CAGR of 8.9%. This expansion is largely driven by Annex-1 compliance requirements, enhancing equipment upgrades and rising demand for automated and small-batch solutions. However, significant capital expenditure for isolators and robotic aseptic lines, along with a lack of skilled labor due to high CDMO staffing, may hinder market growth.
Leading Share for Consumables Segment
The consumables segment has captured the largest market share by product type. This includes vials, syringes, cartridges, stoppers, seals, and disposable systems such as tubing, filters, and connectors. The rising use of prefilled syringes and single-use technologies particularly in biologics and vaccines underscores the demand for high-quality consumables. The trend towards ready-to-use components further bolsters the dominance of consumables by minimizing contamination risks and improving operational efficiency.
CDMOs and biopharma companies are increasingly outsourcing fill-finish activities, necessitating standardized and regulatory-compliant consumables. The expanding pipeline of therapies, including monoclonal antibodies and mRNA products, continues to increase the need for high-performance consumables, making them vital to fill finish processes and key for innovation and value in pharmaceutical manufacturing.
Dominance of CMOs
Contract Manufacturing Organizations (CMOs) hold the largest share of the fill finish market in 2024. Outsourcing by pharmaceutical and biopharmaceutical companies to CMOs is rising due to the need for cost-effective, efficient manufacturing. CMOs offer advantages in aseptic processing, batch size flexibility, and regulatory compliance, turning them into strategic partners. The increasing demand for scalable and quality manufacturing services, especially for biologics and injectables, further solidifies the CMOs’ market position.
European Market Leadership
Europe dominates the fill finish manufacturing market from 2025 to 2030, supported by robust pharmaceutical infrastructure, a comprehensive regulatory framework, and prominent industry players. Germany, Switzerland, France, and the UK host leading companies and CMOs which contribute significantly to the market. The focus on vaccine production and governmental backing for pharmaceutical innovation further enhance the region’s capacity and capabilities in fill finish operations.
- Primary Interviews: Respondents are categorized by Supply Side (70%) and Demand Side (30%).
- Respondent Designation: Managers (45%), CXO and Directors (30%), Executives (25%).
- Region: North America (30%), Europe (30%), Asia Pacific (30%), Latin America (5%), Middle East & Africa (5%).
Key Companies Profiled:
Leading market players include Syntegon Technology GmbH, I.M.A. S.P.A., BD & Co., West Pharmaceutical Services Inc., Gerresheimer AG, AptarGroup Inc., and others. The competition features a variety of corporations with advanced fill finish capabilities, driving innovation and efficiency in the market.
Research Coverage: The research report dissects the fill finish manufacturing market by product, instruments, end users, and regions, exploring drivers, restraints, and market dynamics. It includes a comprehensive analysis of the key industry players to offer insights into their strategies and market positioning.
Key Benefits of the Report: Market leaders and new entrants can utilize this report to grasp revenue estimates, competitive landscapes, and informed strategies for better alignment in the industry. The report’s insights into market drivers, restraints, opportunities, and challenges enable stakeholders to tap into the market’s pulse and leverage strategic advantages.
Insights Include:
- Analysis of drivers, such as GLP-1 and biosimilars’ influence on biologics fill finish volumes, plus Annex-1 compliance.
- Service Development/Innovation provides insights on upcoming technologies in fill finish.
- Market Development and Diversification shows lucrative markets and untapped geographies.
- Competitive Assessment includes detailed strategies and offerings from leading players in the market.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 466 |
| Forecast Period | 2025 – 2030 |
| Estimated Market Value (USD) in 2025 | $18.36 Billion |
| Forecasted Market Value (USD) by 2030 | $28.14 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
Company Profiles
- Syntegon Technology GmbH
- I.M.A. S.P.A.
- Bd & Co
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- Aptargroup, Inc.
- Datwyler Holding Inc.
- Danaher Corporation
- Stevanato Group S.P.A.
- Optima
- Bausch+Strobel
- Groninger & Co. GmbH
- Sgd Pharma
- Schott
- Nipro Corporation
- Bausch Advanced Technology Group
- Maquinaria Industrial Dara, Sl
- Steriline S.R.L.
- Automated Systems of Tacoma, LLC
- Sio2 Materials Science
- Weiler Engineering, Inc.
- Fedegari Autoclavi S.P.A.
- Shandong Pharmaceutical Glass
- Mitsubishi Gas Chemical
- Terumo Corporation
- Skan AG
- Ats Life Science Systems
- Corning Inc.
- Credence Medsystems
- 3P Innovation Ltd.
- Colanar AG.
For more information about this report visit https://www.researchandmarkets.com/r/bkbfvb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Fill Finish Manufacturing Market
